People: King Pharmaceuticals, Inc. (KG)

KG on New York Consolidated

11.35USD
10:42am EST
Price Change (% chg)

$-0.09 (-0.83%)
Prev Close
$11.44
Open
$11.43
Day's High
$11.47
Day's Low
$11.27
Volume
740,321
Avg. Vol
3,370,269
52-wk High
$13.20
52-wk Low
$5.86

view people for:

Markison, Brian 

Brief Biography

Brian A. Markison was elected as Chairman of the Board of King Pharmaceuticals Inc in May 2007. He has been President and Chief Executive Officer and a director since July 2004. He joined King as Chief Operating Officer in March 2004. Mr. Markison served in various positions with Bristol-Myers Squibb beginning in 1982, most recently as President of Bristol-Myers Squibb’s Oncology, Virology and Oncology Therapeutics Network businesses. Between 1998 and 2001, he served variously as Senior Vice President, Neuroscience/Infectious Disease; President, Neuroscience/Infectious Disease/Dermatology; and Vice President, Operational Excellence and Productivity. He also held various sales and marketing positions. Mr. Markison is a member of the Board of Directors of Immunomedics, Inc., a publicly held corporation. He graduated from Iona College in 1982 with a Bachelor of Science degree.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
980,820 -- 1,790,760 6,966,230

Options Compensation

  Quantity Market Value
Excercisable 125,000 781,250.00
Unexercisable 250,000 781,250.00
Excercised -- --
Name Fiscal Year Total
Markison, Brian 6,966,230
Squicciarino, Joseph 3,292,510
Bruce, Eric 1,895,620
Carter, Eric --
Brouillette, Frederick 803,962
Elrod, James 1,797,140
As Of 30 Dec 2008
view people for: